ALN-SOD, an experimental RNA-based therapy being developed for a genetic subtype of amyotrophic lateral sclerosis (ALS) called SOD1-ALS, showed…
Articles by Lila Levinson, PhD
An experimental implantable device from Precision Neuroscience enabled computers to decode brain signals to predict movement and speech, which…
People with diabetes may be less likely to develop amyotrophic lateral sclerosis (ALS) than those without diabetes, according to…
Adding a blood test that measures nerve damage or a test of brain activity to standard diagnostic criteria may help…
Incorporating muscle assessments from whole-body MRIs (WB-MRIs) into the diagnostic process for amyotrophic lateral sclerosis (ALS) may help identify…
An arm of the HEALEY ALS platform trial testing Neurizon Therapeutics’ experimental therapy NUZ-001 as a treatment for…
There is an association between traumatic head injuries and amyotrophic lateral sclerosis (ALS), but the nature of this relationship…
Deaths from amyotrophic lateral sclerosis (ALS) have nearly doubled in Finland over the past three decades, with increases in…
Using seven clinical measures that are fairly easy to assess, researchers have developed a machine learning model to help predict…
FGF21, a hormone that helps cells regulate energy use and respond to stress, may protect muscles and nerve cells from…